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Hospital mortality rates have frequently been improved 
by identifying diagnostic groups with high mortality and 
targeting interventions to those specific groups. We found 
that high residual inpatient mortality persisted after targeted 
measures had achieved an initial reduction, and that the 
causes were spread across a wide range of diagnostic 
groups. Further interventions were put in place consisting 
of a structured electronic mortality form and systematised 
mortality scrutiny and reporting (primary intervention) 
accompanied by a number of quality improvement 
interventions arising from the mortality analysis (secondary 
interventions). We found that those interventions were 
associated with progressive improvements in mortality rates 
and average lengths of inpatient stay over the 5-year study 
period. Winter quarter mortality improvements reached a 
high level of statistical significance but could not be attributed 
to changes in any particular diagnostic groups. We conclude 
that progress with mortality improvements is probably 
best achieved by applying both code-targeted and general 
interventions simultaneously.




Concerns over hospital mortality rates are not new, with qualitative 
descriptions reaching back to at least medieval times. Quantitative 
descriptions of hospital mortality first appeared in the mid-
19th century when Florence Nightingale and William Farr used 
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numerical data to describe the variations in mortality in a number 
of hospitals.1 Nightingale and Farr linked the high mortality among 
hospitalised soldiers to poor standards of hygiene, cleanliness, air 
quality and wound care.2,3 In effect, this was an early example of 
root cause analysis. Their work laid some of the foundations for 
current approaches to the reduction of hospital mortality, namely, 
measure death rates, identify the reasons, consider whether some 
deaths could and should have been avoided, change practice and 
measure any change in the rate. In advanced healthcare systems, 
a considerable amount of work has been done to understand 
and consequently minimise hospital mortality.4–7 In many cases 
the more easily identified specific causes have been ameliorated 
through targeted mortality reduction initiatives. This then leads to 
a more challenging need to reduce mortality across a wide range 
of diagnostic codes. In this paper, we describe the organisational 
response to apparently high unexpected mortality flagged for our 
acute hospital trust in 2013, including our interpretation of the 
data, the need to accept that our already considerable programme 
to improve clinical care was not complete, and the impact and 
significance of a multicomponent intervention to achieve even 
better mortality performance over the subsequent years.
Methods
Background: agreeing the need for a fresh approach
The trust described herein had enjoyed a mid-range position in 
mortality league tables for a number of years until 2011 when a 
high rate of unexpected deaths was found in certain code groups, 
including stroke care and oncology. A close case-by-case audit 
showed that the outlying position for mortality was explained 
to a corrective degree by the allocation of incorrect codes in a 
significant proportion of cases, inadequate documentation of end-
of-life status for some patients, lack of clarity in the identification 
of patients expected to die and the presence of a hospice within 
the acute trust. However, in 2013 the trust was again found to 
have a hospital standardised mortality ratio (HSMR) in the most 
adverse quartile.6 Also, it was not possible to identify diagnostic 
groups that clearly accounted for the adverse index; it appeared 
that higher than average mortality across a range of high-volume 
codes contributed to the overall high HSMR. Of course, as would 
be expected, the largest proportion of contributing cases were 
from the medical directorate, comprising all acute medical 
specialties, including acute geriatric medicine. The admitted case 
mix was very broad and included a large proportion of patients of 
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with severe monopathology illnesses. Clearly, it was no longer 
possible to take corrective action by targeting a small selection 
of diagnostic groups for in-depth cause analysis with a view to 
changing practice and allocating additional resources. A decision 
was therefore taken, with support from senior management, to 
continue to develop and modify services, particularly across the 
medical directorate, in the light of best-practice examples and the 
recommendations of expert bodies such as the Royal Colleges of 
Physicians, the Advancing Quality Alliance and relevant specialist 
medical societies.7–9 Further, it was decided that in addition to the 
mortality indices generated nationally, the trust would make full 
use of its in-house mortality and coding data to track any changes 
in mortality indices from all causes and in sub-groups selected by 
diagnostic code, age and sex.
Interventions to reduce mortality rates
The steps taken by the trust in an attempt to consistently and 
progressively reduce unexpected deaths can be described as 
primary and secondary interventions.
Primary intervention: development and deployment
There was a clear need to bring together the departmental 
morbidity and mortality (MM) activities that were occurring across 
the trust as has been advocated by other studies.10 These were 
highly variable in frequency, content, quality and effectiveness. To 
gain a better understanding, a scoping exercise was conducted in 
2012. This consisted of members of the project team liaising with 
mortality lead clinicians; attending specialty, directorate and MM 
meetings; and gleaning information from the clinical governance 
and audit departments. After wide internal consultation and 
discussion, an acceptable way to address this unsatisfactory state 
was proposed. A structured pro forma for mortality reviews was 
developed, through several plan, do, study, act (PDSA) iterations 
until a version was agreed by representative clinicians as being fit 
for purpose. The pro forma was prepared for exclusively electronic 
use and dubbed the eMortality form. This went on to be piloted 
in three specialties (geriatric medicine, haematology and vascular 
surgery) to detect and correct any operational problems, of which 
there were very few, before a roll-out to all departments.
The primary intervention was therefore the introduction early 
in 2013 of a detailed eMortality data acquisition system across 
all directorates within the trust. All deaths were included and 
the senior doctor responsible for each patient was required, 
through an internal email flagging system, to provide detailed 
structured information and to confirm whether or not the 
death was potentially avoidable. All responses were expected 
to be based on the electronic patient record and other stored 
information, such as imaging and laboratory data. Narrative 
feedback was also recorded to provide guidance for any targeted 
change of practice that might be necessary. Information from 
these individual reviews was then expected to be taken into 
account at departmental or specialty MM meetings, which were 
required to take place at least quarterly. A further layer of scrutiny 
was provided in each individual case by nominated directorate 
mortality leads before an eMortality file was deemed to be 
complete and ready for collective discussion. In 2015 the process 
was arguably strengthened by having the initial review performed 
by a senior doctor other than the one responsible for the clinical 
care of the patient, usually from the same or a similar field of 
practice. The development of the eMortality form was iterative 
and in 2017 was modified further by taking into account the 
principles of structured judgement.9 Each directorate had a senior 
clinician nominated to ensure these actions took place, with overall 
scrutiny by the Trust Mortality Surveillance Group (TMSG).
Secondary interventions: identification and action plan
It became apparent from an early stage in the scrutiny of 
eMortality information arising from the primary intervention, 
coupled with a critical appraisal of reported adverse incidents 
and near misses, that certain recurrent issues contributed to the 
less-than-perfect care given to some patients, particularly in the 
first two days after admission to hospital. Information gleaned 
from the process was disseminated through a regular mortality 
newsletter to clinical staff.
Based on the findings of the primary intervention actions were 
taken, mainly in the latter 6 months of 2013, to address the 
issues identified. Some of these were new initiatives and some 
consisted of better implementation of existing interventions 
through local guideline revision, active promotion of good practice 
through departmental and trust educational events, celebration 
of improved practice in trust staff communication media and 
targeting weak areas that required additional resources to support 
improvements. Specific secondary interventions included: 
> the introduction of a unified electronic vital sign recording and 
early warning scoring system (Vital Pack®) across the trust 
supported by a rollout training programme
> adopting and promoting the National Institute for Health 
and Care Excellence intravenous fluid guideline, reinforcing 
the guideline during medical and nursing training events and 
requiring all consultant medical staff to have annual fluid 
management training
> generating and implementing a new acute kidney injury (AKI) 
management policy based on current best evidence and 
practice
> active promotion of the trust's sepsis guideline through in-house 
media and in trust mandatory training.
> a service shift that allowed senior doctors to be present in the 
hospital to review newly admitted patients and deteriorating 
patients outside ordinary working hours on weekdays and at 
weekends
> a revised nursing template to maximise the presence and 
distribution of experienced nurses in acute areas of the hospital
> introduction of daily ambulatory clinics in geriatric medicine 
and acute medicine to review selected patients soon after 
discharge, or by referral from the community
> development of an electronic process for mortality reviews and 
dissemination of learning from deaths.
The main purpose of the study described in this paper was to 
explore the concordance and temporal relationship between the 
introduction of measures such as those described above and 
changes in a number of indicators including mortality and average 
length of stay (LOS) in hospital from 2012–2017.
Location
The study took place in a large acute NHS trust composed of 
two sites: Royal Bournemouth Hospital (RBH) which is a general 
acute hospital with around 500 beds receiving most specialties 
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except paediatrics, major trauma and obstetrics; and Christchurch 
Hospital which provides mainly outpatient services but includes 
a 16-bed residential specialist palliative care unit (Macmillan unit 
(MU)) for patients with end-of-life conditions.
Data definitions and sources
Crude mortality rate (CMR) was defined as the number of 
inpatient deaths divided by the number of admissions. CMR data 
were extracted electronically for admissions to the RBH and the 
MU after filtering out emergency department (ED) attendances 
and day cases. All elective and non-elective admissions were 
included. The HSMR and summary hospital-level mortality 
indicator (SHMI) were extracted from national data sources.
LOS was defined as the average number of days in hospital for 
elective and non-elective admissions to the RBH and the MU 
where the LOS was more than 24 hours.
To illustrate the impact of various interventions, a time series was 
created to investigate the likely effect on inpatient CMR and LOS. 
Corresponding HSMR and SHMI values were also included in the 
analytic matrix to explore the correlation within adjusted and non-
adjusted mortality indices.
Statistical method
Multiple correlations within the time series were studied and 
calculations were done to identify statistically significant 
differences in outcomes and to determine whether this could 
be attributed to any specific intervention. Analysis of variance 
(ANOVA; for single and double factors) was used to test for any 
significant correlation in CMRs for financial years from 2012/13 
to 2016/17. Variance was also studied for quarterly indices to take 
account of variations in winter months. Each p value was adjusted 
for the number of groups being studied (Bonferroni correction). 
Any significant variation was compared by correlation to the 
intervention(s) within that time frame (Fig 1). 
Results
Results from the primary intervention
In a relatively short period, there was a sufficient volume of 
information to indicate that some potentially avoidable deaths 
could be attributed to less-than-ideal management of a number 
of relatively common conditions across a number of diagnostic 
groups including, but not confined to, sepsis, acute kidney injury 
and heart failure, with some particular concerns regarding 
inconsistencies in an important minority of cases with respect to 
intravenous fluid management, the prompt initiation of antibiotics 
and early senior specialist review. However, no simple pattern 
emerged and there was no indication of grossly inadequate or 
negligent practice. Though the majority of patients, including 
those who died, had received very good care there seemed to be a 
need for an all-round improvement in the quality of care to ensure 
that fewer patients would be at risk.
Association between the interventions and rates of 
mortality and LOS over time
We found that CMR, HSMR and SHMI all showed a declining trend 
over the 5-financial year study period (Fig 1). The improvement 
in the mortality rates did not reach statistical significance when 
compared across whole financial years (Table 1), either within the 
group or between the groups. However, when a similar ANOVA was 
applied to a quarterly analysis of the mortality figures, a significant 
variation in the quarterly mortality rates, largely winter quarters, 
was found when compared across the most recent 5 years (quarter 
Fig 1. The timing of interventions and the changes in mortality indicators from 2011 to 2017. 1 = October 2013: trust-wide rollout of eMortality 
review. 2 = September 2014: sepsis collaborative to monitor and improve. 3 = January 2014: VitalPAC for recording vital signs electronically. 4 = March 
2014: acute kidney injury guidelines enhanced consultants’ cover over the weekends. 5 = November 2014: ambulatory clinics in acute and geriatric medicine. 
6 = March 2015: extended acute medical unit working into evenings. 7 = December 2015: intravenous fluid management. 8 = January 2016: quarterly 
publication of mortality newsletter. 9 = August 2015: culture change champions. 10 = December 2016: deteriorating patient collaborative. HSMR = hospital 
standardised mortality ratio; RBCHT = The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust for all admissions including the Macmillan 
unit; RBH = the Royal Bournemouth Hospital site only; SHMI = summary hospital-level mortality indicator.
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Table 1. Comparison of crude mortality rates and average lengths of stay between quarters and whole years
Financial year  
Quarter
Crude mortality,  
n (%)
Crude mortality,  
p value
Average length  
of stay, days
Length of stay,  
p value
2012/13 Vs 2013/14, 0.22 7.2 Vs 2013/14, 0.28
Vs 2014/15, 0.81 Vs 2014/15, 0.04
Vs 2015/16, 0.06 Vs 2015/16, 0.003
Vs 2016/17, 0.26 Vs 2016/17, 0.0003
 Q1 316 (3.1)
 Q2 341 (3.3)
 Q3 331 (3.1)
 Q4 422 (4.0)
2013/14 Vs 2012/13, 0.22 7.4 Vs 2012/13, 0.28
Vs 2014/15, 0.40 Vs 2014/15, 0.03
Vs 2015/16, 0.67 Vs 2015/16, 0.01
Vs 2016/17, 0.91 Vs 2016/17, 0.007
 Q1 328 (3.7)
 Q2 264 (3.2)
 Q3 306 (3.5)
 Q4 350 (3.6)
2014/15 Vs 2012/13, 0.81 6.8 Vs 2012/13, 0.04
Vs 2013/14, 0.40 Vs 2013/14, 0.03
Vs 2015/16, 0.24 Vs 2015/16, 0.88
Vs 2016/17, 0.45 Vs 2016/17, 0.01
 Q1 314 (3.4)
 Q2 275 (2.9)
 Q3 380 (4.0)
 Q4 404 (4.5)
2015/16 Vs 2012/13, 0.06 6.8 Vs 2012/13, 0.003
Vs 2013/14, 0.67 Vs 2013/14, 0.01
Vs 2014/15, 0.24 Vs 2014/15, 0.88
Vs 2016/17, 0.59 Vs 2016/17, 0.003
 Q1 306 (3.4)
 Q2 286 (3.1)
 Q3 293 (3.2)
 Q4 327 (3.6)
2016/17 Vs 2012/13, 0.26 6.1 Vs 2012/13, 0.0003
Vs 2013/14, 0.91 Vs 2013/14, 0.007
Vs 2014/15, 0.45 Vs 2014/15, 0.01
Vs 2015/16, 0.59 Vs 2015/16, 0.003
 Q1 321 (3.2)
 Q2 269 (2.7)
 Q3 308 (3.1)
 Q4 362 (3.6)
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1 vs quarter 4, p=0.006; quarter 2 vs quarter 4, p=0.002; quarter 
3 vs quarter 4, p=0.03). Mortality rates for quarter 4 remained 
high when compared to other quarters, however, within group 
analysis showed downward trend over the years which was not 
statistically significant (p=0.031). Also, the average LOS improved 
significantly over the years in an approximately linear manner and 
the apparent correlation became stronger from year to year (Table 
1). However, there was no direct correlation observed between 
improved mortality rates and decreased LOS.
In summary, the overall mortality rates improved over the 5 
years and all three measures currently monitored by the mortality 
committee of the trust (CMR, HSMR, SHMI) tended to improve to 
a similar degree. The mortality trends were more informative than 
individual rates calculated at a cross-sectional point. Apparent 
excess mortality detected at points in time could therefore be 
misleading.
Responses within the organisation
Interestingly, the project team found that clinical directorates 
and individual clinicians were highly supportive of the full 
range of interventions despite the additional time burden 
of mandatory MM meetings. The reasons for this are clearly 
complex, but important factors reported by clinical staff include 
wholehearted support from senior management (particularly the 
trust medical director and chief executive), additional financial 
resources committed to quality improvement and a deep-seated 
organisational culture that acknowledged the value of work to 
improve outcomes generally and mortality rates in particular. 
Within a few months of the start of the primary intervention, all 
directorates had adopted the required frequency, content and 
reporting structure for formal mortality meetings. Attendance 
levels by consultant staff were initially high and have been 
sustained, at least partly due to the requirements of annual 
appraisal.
Discussion
Our findings indicate that a persistent hospital-wide approach 
to general clinical quality improvement, coupled with focused 
analysis of selected clinical topics and specific cases is associated 
with a falling trend in hospital mortality. An important learning 
point to emerge from this study is the need to pay heed to clinical 
practice across the full range of activities and not simply focus 
attention, and resources, on specific conditions. This appears to 
be especially important once exceptional but easily identified 
causes of excess mortality, for example methicillin-resistant 
Staphylococcus aureus, have already been tackled.
Further, our study suggests that trends in mortality rates should 
act as the primary driver for quality improvement programmes 
and changes in clinical culture and configuration. For example, 
the improvements we observed in mortality trends over winter 
quarters, even though winter mortality remained comparatively 
high, indicates that the planning for, and management of, high 
volume and high acuity quarters should be an important part of 
quality improvement projects.
We coincidentally found a reduction in mean LOS in hospital that 
approximately tracked the reduction in mortality rates. While it 
would be simplistic to infer any direct causal link between those 
observations, it seems likely that the interventions that improved 
the quality of care and, hence, mortality rate could also have led 
to shortened LOS. Specific examples that are strongly supported 
by anecdotal evidence is the timely identification and treatment 
of sepsis and AKI. Indeed, in the case of the latter there might be 
scope for further improvements by the use of artificial intelligence 
to anticipate AKI and other conditions in the future.11 Such 
technological developments underline the need for hospitals and 
other healthcare organisations to continually service and revise 
their quality programmes to take account of new methods to 
improve the care of their patients.
Though our experience is encouraging, there needs to be a 
note of caution when considering the generalisability of our 
approach. This is partly because of variations in the quality of 
mortality data between organisations. That is a limiting factor 
to any retrospective study of this type, as is the inevitable lack 
of a parallel comparison group and the near impossibility of 
capturing and describing the fine grain of day-to-day quality 
work at the operational level. Also, the methods employed for 
the measurement of hospital mortality remain controversial.12,13 
There is no overall consensus on which measure is of the most 
value as a platform for mortality audit, quality improvement and 
service development. General acute hospitals inevitably have high 
CMRs and it is difficult, and potentially misleading, to establish 
a CMR threshold that indicates good or defines inadequate care, 
even when comparing hospitals that are superficially similar. The 
HSMR and SHMI and other indices deploy various adjustment 
criteria that have been shown to be sufficiently divergent to 
place the individual hospitals in the best or worst groups in 
mortality league tables depending on the index used.12–16 
That said, it is clearly neither practical nor morally defensible 
to disregard mortality comparisons. An adverse HSMR or SHMI 
must be taken seriously and should always prompt a hospital 
to examine the reasons for the finding. This might be relatively 
straightforward when excess mortality rates are clearly confined 
to a particular code or set of codes, or a defined area of practice. 
Corrective action can then be targeted. Cause analysis is much 
more difficult when high mortality rates are diffused across a 
large proportion of the caseload, and corrective action is then 
correspondingly less easily defined and executed.16 To some 
extent, these factors can be understood and consequently taken 
into consideration in the methods embedded in the UK National 
Mortality Review and the analysis of the causes of mortality 
that form the principles of a structured judgement approach to 
avoidable mortality reduction as developed and recommended 
by the Royal College of Physicians and NHS Improvement.7,9 
Organisations, mainly hospitals, in the UK and elsewhere have 
attempted to define thresholds for acceptable mortality rates, 
understand the reasons for exceeding such thresholds and 
build sustainable systems to monitor mortality status and take 
effective action. Such examples have usually employed a mix of 
national data and recommendations blended with local data, 
case mix, organisational culture, strengths and weaknesses to 
find a workable pattern.17 Our approach and subsequent action 
plan are similar to that taken in other large acute hospitals with 
comparable declining mortality trends.10,18,19 There is, therefore, 
growing evidence that a persistent, detailed and iterative 
approach to quality improvement in hospitals is effective. 
Comparable approaches taken in primary care and in specialised 
hospital units have also resulted in improvements but can be less 
confidently compared with our experience due to their different 
clinical substrate.20,21 Nevertheless, the overall principle of 
measure, analyse, plan, act and re-measure remains intact.
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Conclusion
Most published studies of the systematic approaches taken to 
reduce hospital mortality have linked reductions to the measures 
taken to improve the management of the specifically identified 
diagnostic groups shown to account for the adverse local mortality 
rates. This has generally been observed irrespective of the 
mortality index used. The findings presented in this paper indicate 
that, after a code-targeted regimen has achieved initial reductions 
in mortality indices, a further progressive fall is associated with 
a broad-based incremental clinical quality improvement based 
on structured iterative mortality review, information sharing, 
informed service reconfiguration, evidence-based investment 
in equipment, and staff and trust-wide repetitive application of 
measures found to be effective. We suggest that all mortality 
indicators can be used to monitor improvements in mortality 
trends and the most effective pathway to low and sustainable 
hospital inpatient mortality is to deploy targeted and broad-based 
mortality reduction programmes simultaneously. n
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